Popular Articles

Lutonix, Inc. Announces First Patient Enrollments In Three Separate Clinical Trials
Lutonix, Inc., a privately held medical device start-up, announced that patient enrollment is underway for its three simultaneous first-in-human clinical trials. The three studies are designed to test whether the proprietary Lutonix Drug Coated Balloon (DCB) Catheter is safe and effective in the treatment of vascular narrowing.
generic viagra online
For Research On Protective Effects Of Fish Oil In Stroke LSUHSC MD/PHD Student Awarded NIH Grant
Tiffany Niemoller, a 5th year MD/PhD student at LSU Health Sciences Center New Orleans Schools of Medicine and Graduate Studies, has been awarded a grant in the amount of $148,480 over four years by the National Institute on Aging of the National Institutes of Health. A training grant for individual predoctoral students, the Ruth L. Kirschstein National Research Service Award is an individual fellowship (F30) is given to "promising applicants with the potential to become productive, independent, highly trained physician-scientists." It is a very competitive grant. The project is being supported with funds from the American Recovery and Reinvestment Act.
News of the day
Sol-Gel Anti-Acne Clinical Study Shows Significantly Improved Efficacy And Safety
Sol-Gel Technologies Ltd, a specialty pharmaceuticals company, announced today results from a comparative clinical study. The results demonstrate that the company"s two strength Anti-Acne kits achieved pronounced efficacy and markedly improved tolerability. The study will be presented at the 10th International Congress of Dermatology in Prague, May 20-23, 2009.
Health Insurance

Swine Flu Daily Update Issued At: 11am Friday 3 July 2009, Wales

Assembly Government

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):